Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001079973-25-000276·ENDRA Life Sciences Inc.
Schedule 13G ownership disclosure
ENDRA LIFE SCIENCES INC
Common Stock, par value $0.0001 per share · CUSIP: 29273B302
Event date: 2024-12-31
- Filing-level shares
- 35,589.00
- Percent of class
- 6.22%
- L1 Capital Global Opportunities Master Fund, Ltd.
Shares: 35,589.00 · Class: 6.22%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001079973-25-000276
- Form type
- SCHEDULE 13G/A
- Filer
- ENDRA Life Sciences Inc.
- CIK
- CIK 1681682
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership